These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32754609)
21. Virus-associated immune thrombocytopenic purpura in childhood. Yenicesu I; Yetgin S; Ozyürek E; Aslan D Pediatr Hematol Oncol; 2002 Sep; 19(6):433-7. PubMed ID: 12186367 [TBL] [Abstract][Full Text] [Related]
22. Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines. Shimanovsky A; Patel D; Wasser J Mediterr J Hematol Infect Dis; 2016; 8(1):e2016010. PubMed ID: 26740871 [TBL] [Abstract][Full Text] [Related]
23. High level antibodies to TORCH in the IVIG preparation from Taiwanese. Chou YL; Hsieh KH; Perng CL; Fan HC; Tien CH; Wang CC; Chen SJ; Chang FW J Chin Med Assoc; 2019 Jun; 82(6):510-514. PubMed ID: 31180949 [TBL] [Abstract][Full Text] [Related]
24. Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature. Owatanapanich S; Wanlapakorn N; Tangsiri R; Poovorawan Y Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1053-7. PubMed ID: 25417506 [TBL] [Abstract][Full Text] [Related]
25. Infant case of severe immune thrombocytopenia caused by COVID-19 infection. Anzai T; Nakashima N; Betsui H; Kawahara Y; Hayashi Y; Kimura H; Shimada A EJHaem; 2023 Nov; 4(4):1148-1151. PubMed ID: 38024599 [TBL] [Abstract][Full Text] [Related]
26. Other immune thrombocytopenias. Liebman H Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469 [TBL] [Abstract][Full Text] [Related]
27. Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. Qasim H; Ali E; Yassin MA IDCases; 2021; 26():e01344. PubMed ID: 34804803 [TBL] [Abstract][Full Text] [Related]
28. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Jensen IP; Vestergaard BF Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681 [TBL] [Abstract][Full Text] [Related]
29. Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up. Ye X; Xiao X; Li B; Zhu W; Li Y; Wu J; Huang X; Jin J; Chen D; Jin J; Huang J Front Oncol; 2020; 10():1272. PubMed ID: 32719750 [No Abstract] [Full Text] [Related]
30. The Influence of Primary Cytomegalovirus or Epstein-Barr Virus Infection on the Course of Idiopathic Thrombocytopenic Purpura. Smalisz-Skrzypczyk K; Romiszewski M; Matysiak M; Demkow U; Pawelec K Adv Exp Med Biol; 2016; 878():83-8. PubMed ID: 26269027 [TBL] [Abstract][Full Text] [Related]